Duration of antiviral immunity after smallpox vaccination - PubMed (original) (raw)
doi: 10.1038/nm917. Epub 2003 Aug 17.
Affiliations
- PMID: 12925846
- DOI: 10.1038/nm917
Free article
Duration of antiviral immunity after smallpox vaccination
Erika Hammarlund et al. Nat Med. 2003 Sep.
Free article
Abstract
Although naturally occurring smallpox was eliminated through the efforts of the World Health Organization Global Eradication Program, it remains possible that smallpox could be intentionally released. Here we examine the magnitude and duration of antiviral immunity induced by one or more smallpox vaccinations. We found that more than 90% of volunteers vaccinated 25-75 years ago still maintain substantial humoral or cellular immunity (or both) against vaccinia, the virus used to vaccinate against smallpox. Antiviral antibody responses remained stable between 1-75 years after vaccination, whereas antiviral T-cell responses declined slowly, with a half-life of 8-15 years. If these levels of immunity are considered to be at least partially protective, then the morbidity and mortality associated with an intentional smallpox outbreak would be substantially reduced because of pre-existing immunity in a large number of previously vaccinated individuals.
Comment in
- Keeping the lock on smallpox.
Weiner DB. Weiner DB. Nat Med. 2003 Sep;9(9):1115-6. doi: 10.1038/nm0903-1115. Nat Med. 2003. PMID: 12949522 No abstract available.
Similar articles
- Antiviral immunity following smallpox virus infection: a case-control study.
Hammarlund E, Lewis MW, Hanifin JM, Mori M, Koudelka CW, Slifka MK. Hammarlund E, et al. J Virol. 2010 Dec;84(24):12754-60. doi: 10.1128/JVI.01763-10. Epub 2010 Oct 6. J Virol. 2010. PMID: 20926574 Free PMC article. - Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA. Kennedy JS, et al. J Infect Dis. 2004 Oct 1;190(7):1286-94. doi: 10.1086/423848. Epub 2004 Aug 30. J Infect Dis. 2004. PMID: 15346340 Clinical Trial. - The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW. Kim SH, et al. Clin Microbiol Infect. 2007 Jan;13(1):91-3. doi: 10.1111/j.1469-0691.2006.01576.x. Clin Microbiol Infect. 2007. PMID: 17184294 - Immunity and immunological memory following smallpox vaccination.
Amanna IJ, Slifka MK, Crotty S. Amanna IJ, et al. Immunol Rev. 2006 Jun;211:320-37. doi: 10.1111/j.0105-2896.2006.00392.x. Immunol Rev. 2006. PMID: 16824139 Review. - [Jenner's cowpox vaccine in light of current vaccinology].
Huygelen C. Huygelen C. Verh K Acad Geneeskd Belg. 1996;58(5):479-536; discussion 537-8. Verh K Acad Geneeskd Belg. 1996. PMID: 9027132 Review. Dutch.
Cited by
- African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.
Zhu JJ. Zhu JJ. Viruses. 2022 Sep 13;14(9):2021. doi: 10.3390/v14092021. Viruses. 2022. PMID: 36146827 Free PMC article. Review. - Area under Immunosurveillance: Dedicated Roles of Memory CD8 T-Cell Subsets.
Parga-Vidal L, van Gisbergen KPJM. Parga-Vidal L, et al. Cold Spring Harb Perspect Biol. 2020 Nov 2;12(11):a037796. doi: 10.1101/cshperspect.a037796. Cold Spring Harb Perspect Biol. 2020. PMID: 32839203 Free PMC article. Review. - Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein.
Harbour JC, Lyski ZL, Schell JB, Thomas A, Messer WB, Slifka MK, Nolz JC. Harbour JC, et al. J Immunol. 2021 Jun 1;206(11):2596-2604. doi: 10.4049/jimmunol.2100054. Epub 2021 May 10. J Immunol. 2021. PMID: 33972374 Free PMC article. - Listeria monocytogenes: a model pathogen to study antigen-specific memory CD8 T cell responses.
Khan SH, Badovinac VP. Khan SH, et al. Semin Immunopathol. 2015 May;37(3):301-10. doi: 10.1007/s00281-015-0477-5. Epub 2015 Apr 10. Semin Immunopathol. 2015. PMID: 25860798 Free PMC article. Review. - Use it or lose it: establishment and persistence of T cell memory.
Kedzierska K, Valkenburg SA, Doherty PC, Davenport MP, Venturi V. Kedzierska K, et al. Front Immunol. 2012 Nov 27;3:357. doi: 10.3389/fimmu.2012.00357. eCollection 2012. Front Immunol. 2012. PMID: 23230439 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- T32 HL007781/HL/NHLBI NIH HHS/United States
- P51 RR000163/RR/NCRR NIH HHS/United States
- T32HL07781/HL/NHLBI NIH HHS/United States
- RR00163/RR/NCRR NIH HHS/United States
- AI21640/AI/NIAID NIH HHS/United States
- AI051346/AI/NIAID NIH HHS/United States
- R01 AI051346/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical